Director/PDMR Shareholding

Hikma Pharmaceuticals Plc

13 April 2026

 

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 13 April 2026: Hikma Pharmaceuticals PLC (LSE: HIK) (Nasdaq Dubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMRs") have received shares as a result of the vesting of their conditional share awards which were granted on 9 April 2024 under the 2023 Long-Term Incentive Plan ("LTIP").

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Julie Hill

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Julie Hill
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the LTIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	8,188
d)	Aggregated information	Price(s): nil Volume(s): 8,188
e)	Date of the transaction	9 April 2026
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the LTIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£13.09	3,121
d)	Aggregated information	Price(s): £13.09 Volume(s): 3,121 Total(s): £40,851.53
e)	Date of the transaction	9 April 2026
f)	Place of the transaction	London Stock Exchange (XLON)

Sam Park

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Sam Park
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the LTIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	19,045
d)	Aggregated information	Price(s): nil Volume(s): 19,045
e)	Date of the transaction	9 April 2026
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ("Shares") ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the LTIP.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£13.09	7,259
d)	Aggregated information	Price(s): £13.09 Volume(s): 7,259 Total(s): £95,014.82
e)	Date of the transaction	9 April 2026
f)	Place of the transaction	London Stock Exchange (XLON)

Helen Middlemist
Group Company Secretary

[phone]

 

END